secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vyome Holdings, Inc (HIND)
CIK:        0001427570
Form:       8-K
Filed at:   2025-07-15T23:59:59+00:00
Accession:  0001104659-25-068082
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ReShape furnishes investor presentation for pending Vyome merger, new ticker HIND
--------------------------------------------------------------------------------

- Filed investor presentation slides on July 15, 2025 in connection with proposed merger with Vyome Therapeutics.
- Presentation describes Vyome as a US-India clinical-stage platform focused on immuno-inflammation assets.
- Combined company expected to trade on Nasdaq under ticker symbol HIND (pending stockholder and regulatory approvals).
- Merger and asset sale subject to stockholder vote; joint proxy statement/prospectus filed June 24, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925068082/0001104659-25-068082-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1427570/000110465925068082/tm2519769d2_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-068082

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer